A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies

From MaRDI portal
Publication:2206325






Cites work







This page was built for publication: A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2206325)